UBS Group’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312M | Sell |
700,002
-37,416
| -5% | -$16.7M | 0.05% | 300 |
|
|
2025
Q1 | $358M | Sell |
737,418
-125,618
| -15% | -$60.9M | 0.07% | 253 |
|
|
2024
Q4 | $348M | Buy |
863,036
+88,821
| +11% | +$35.8M | 0.06% | 238 |
|
|
2024
Q3 | $360M | Buy |
774,215
+179,835
| +30% | +$83.6M | 0.08% | 192 |
|
|
2024
Q2 | $279M | Buy |
594,380
+22,200
| +4% | +$10.4M | 0.07% | 216 |
|
|
2024
Q1 | $239M | Buy |
572,180
+148,474
| +35% | +$62.1M | 0.06% | 245 |
|
|
2023
Q4 | $172M | Buy |
423,706
+71,008
| +20% | +$28.9M | 0.05% | 267 |
|
|
2023
Q3 | $123M | Sell |
352,698
-131,183
| -27% | -$45.6M | 0.04% | 321 |
|
|
2023
Q2 | $170M | Sell |
483,881
-58,264
| -11% | -$20.5M | 0.06% | 261 |
|
|
2023
Q1 | $171M | Sell |
542,145
-63,417
| -10% | -$20M | 0.06% | 249 |
|
|
2022
Q4 | $175M | Buy |
605,562
+322,784
| +114% | +$93.2M | 0.07% | 238 |
|
|
2022
Q3 | $81.9M | Sell |
282,778
-25,916
| -8% | -$7.5M | 0.04% | 374 |
|
|
2022
Q2 | $87M | Sell |
308,694
-102,651
| -25% | -$28.9M | 0.04% | 386 |
|
|
2022
Q1 | $107M | Buy |
411,345
+54,874
| +15% | +$14.3M | 0.04% | 379 |
|
|
2021
Q4 | $78.3M | Sell |
356,471
-146,377
| -29% | -$32.1M | 0.02% | 505 |
|
|
2021
Q3 | $91.2M | Buy |
502,848
+54,804
| +12% | +$9.94M | 0.03% | 437 |
|
|
2021
Q2 | $90.3M | Buy |
448,044
+9,852
| +2% | +$1.99M | 0.03% | 429 |
|
|
2021
Q1 | $94.2M | Buy |
438,192
+79,543
| +22% | +$17.1M | 0.03% | 409 |
|
|
2020
Q4 | $84.8M | Buy |
358,649
+151,378
| +73% | +$35.8M | 0.03% | 403 |
|
|
2020
Q3 | $56.4M | Sell |
207,271
-59,517
| -22% | -$16.2M | 0.02% | 477 |
|
|
2020
Q2 | $77.5M | Sell |
266,788
-102,485
| -28% | -$29.8M | 0.03% | 346 |
|
|
2020
Q1 | $87.9M | Buy |
369,273
+68,650
| +23% | +$16.3M | 0.04% | 301 |
|
|
2019
Q4 | $65.8M | Sell |
300,623
-27,111
| -8% | -$5.94M | 0.02% | 479 |
|
|
2019
Q3 | $55.5M | Buy |
327,734
+75,783
| +30% | +$12.8M | 0.02% | 518 |
|
|
2019
Q2 | $46.2M | Buy |
251,951
+1,657
| +0.7% | +$304K | 0.02% | 576 |
|
|
2019
Q1 | $46M | Sell |
250,294
-23,776
| -9% | -$4.37M | 0.02% | 568 |
|
|
2018
Q4 | $45.4M | Sell |
274,070
-98,400
| -26% | -$16.3M | 0.02% | 496 |
|
|
2018
Q3 | $71.8M | Buy |
372,470
+17,670
| +5% | +$3.41M | 0.03% | 410 |
|
|
2018
Q2 | $60.3M | Sell |
354,800
-14,660
| -4% | -$2.49M | 0.03% | 444 |
|
|
2018
Q1 | $60.2M | Buy |
369,460
+55,878
| +18% | +$9.11M | 0.03% | 430 |
|
|
2017
Q4 | $47M | Buy |
313,582
+68,501
| +28% | +$10.3M | 0.02% | 536 |
|
|
2017
Q3 | $37.3M | Buy |
245,081
+500
| +0.2% | +$76K | 0.02% | 582 |
|
|
2017
Q2 | $31.5M | Buy |
244,581
+81,580
| +50% | +$10.5M | 0.02% | 617 |
|
|
2017
Q1 | $17.8M | Sell |
163,001
-82,528
| -34% | -$9.02M | 0.01% | 861 |
|
|
2016
Q4 | $18.1M | Buy |
245,529
+14,173
| +6% | +$1.04M | 0.01% | 808 |
|
|
2016
Q3 | $20.2M | Buy |
231,356
+45,262
| +24% | +$3.95M | 0.01% | 755 |
|
|
2016
Q2 | $16M | Sell |
186,094
-24,935
| -12% | -$2.14M | 0.01% | 831 |
|
|
2016
Q1 | $16.8M | Sell |
211,029
-84,862
| -29% | -$6.75M | 0.01% | 784 |
|
|
2015
Q4 | $37.2M | Buy |
295,891
+62,634
| +27% | +$7.88M | 0.02% | 502 |
|
|
2015
Q3 | $24.3M | Sell |
233,257
-32,010
| -12% | -$3.33M | 0.02% | 605 |
|
|
2015
Q2 | $32.8M | Sell |
265,267
-21,605
| -8% | -$2.67M | 0.02% | 562 |
|
|
2015
Q1 | $33.8M | Sell |
286,872
-41,744
| -13% | -$4.92M | 0.02% | 548 |
|
|
2014
Q4 | $39M | Buy |
+328,616
| New | +$39M | 0.03% | 512 |
|